Business Description
Integral Diagnostics Ltd
ISIN : AU000000IDX2
Total Employee Number:
1,977Description
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.89 | |||||
Debt-to-EBITDA | 5.02 | |||||
Interest Coverage | 2.86 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.05 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.5 | |||||
3-Year EBITDA Growth Rate | -4.7 | |||||
3-Year FCF Growth Rate | 1.5 | |||||
3-Year Book Growth Rate | 7.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 19.36 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.28 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -52.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.63 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.26 | |||||
Days Inventory | 28.71 | |||||
Days Sales Outstanding | 14.34 | |||||
Days Payable | 519.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 1.59 | |||||
3-Year Dividend Growth Rate | -19 | |||||
3-Year Average Share Buyback Ratio | -17.6 | |||||
Shareholder Yield % | -16.18 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.56 | |||||
Operating Margin % | 9.18 | |||||
Net Margin % | 1.83 | |||||
EBITDA Margin % | 15.6 | |||||
FCF Margin % | 3.46 | |||||
OCF Margin % | 10.97 | |||||
ROE % | 2.04 | |||||
ROA % | 1 | |||||
ROIC % | 2.85 | |||||
3-Year ROIIC % | 0.03 | |||||
ROC (Joel Greenblatt) % | 10.95 | |||||
ROCE % | 3.94 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 47.62 | |||||
Forward PE Ratio | 9.35 | |||||
PE Ratio without NRI | 47.62 | |||||
Shiller PE Ratio | 25.25 | |||||
Price-to-Owner-Earnings | 20 | |||||
PS Ratio | 0.96 | |||||
PB Ratio | 1.1 | |||||
Price-to-Free-Cash-Flow | 27.78 | |||||
Price-to-Operating-Cash-Flow | 8.73 | |||||
EV-to-EBIT | 26.4 | |||||
EV-to-Forward-EBIT | 17.24 | |||||
EV-to-EBITDA | 10.99 | |||||
EV-to-Forward-EBITDA | 8.93 | |||||
EV-to-Revenue | 1.71 | |||||
EV-to-Forward-Revenue | 1.87 | |||||
EV-to-FCF | 49.34 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Projected-FCF | 0.76 | |||||
Earnings Yield (Greenblatt) % | 3.79 | |||||
FCF Yield % | 3.58 | |||||
Forward Rate of Return (Yacktman) % | -16.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ITGDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Integral Diagnostics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 505.161 | ||
| EPS (TTM) ($) | 0.027 | ||
| Beta | -0.1296 | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.43 | ||
| Volatility % | 52.77 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 1 | ||
| 12-1 Month Momentum % | -52.38 | ||
| 52-Week Range ($) | 1 - 2.1 | ||
| Shares Outstanding (Mil) | 373.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Integral Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Integral Diagnostics Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-10-30 | In 123 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-26 11:00 | In 59 days | ||
| Annual report for 2026 | 2026-08-26 | In 58 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-26 | In 58 days | ||
| AUD 0.033000 Cash Dividend | 2026-03-04 | 1.00 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-02-24 11:00 | 1.00 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-02-24 | 1.00 (+0.00%) | ||
| General meeting for 2025 | 2025-10-31 | 1.00 (+0.00%) | ||
| AUD 0.040000 Cash Dividend | 2025-08-29 | 2.10 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-08-26 11:00 | 2.10 (+0.00%) |
Show
Entries
Integral Diagnostics Ltd Frequently Asked Questions
What is Integral Diagnostics Ltd(ITGDF)'s stock price today?
The current price of ITGDF is $1.00. The 52 week high of ITGDF is $2.10 and 52 week low is $1.00.
When is next earnings date of Integral Diagnostics Ltd(ITGDF)?
The next earnings date of Integral Diagnostics Ltd(ITGDF) is 2026-08-26 Est..
Does Integral Diagnostics Ltd(ITGDF) pay dividends? If so, how much?
Integral Diagnostics Ltd(ITGDF) does not pay dividend.
Guru Commentaries on OTCPK:ITGDF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Integral Diagnostics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers